Abstract |
Pacemaker implantation following tricuspid valve surgery remains challenging, but recent developments in lead technology have significantly improved the options for ventricular pacing. In the presence of significant tricuspid regurgitation, steroid-eluting active-fixation leads should be used routinely, and in patients with a tricuspid prosthesis, the use of a dedicated cardiac venous pacing system is likely to be the best option.
|
Authors | Neil C Davidson, Harry G Mond |
Journal | Pacing and clinical electrophysiology : PACE
(Pacing Clin Electrophysiol)
Vol. 25
Issue 2
Pg. 129-31
(Feb 2002)
ISSN: 0147-8389 [Print] United States |
PMID | 11915977
(Publication Type: Comment, Editorial)
|
Topics |
- Ebstein Anomaly
(therapy)
- Electrodes, Implanted
- Heart Valve Prosthesis Implantation
- Humans
- Pacemaker, Artificial
- Tricuspid Valve
(surgery)
- Tricuspid Valve Insufficiency
(therapy)
|